T. Kauffman

发表

Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium

Marian J. Gilmore, B. Bernhardt, J. Wynn, 2018, Journal of Genetic Counseling.

Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium.

B. Wilfond, P. Appelbaum, B. Bernhardt, 2019, Personalized medicine.

Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza

A. Naleway, S. Bozeman, M. Thompson, 2019, BMC Pregnancy and Childbirth.

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy

Elizabeth M Webber, Elizabeth M. Webber, K. Goddard, 2015, BMC Cancer.

Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system

Marian J. Gilmore, K. Goddard, H. Feigelson, 2022, Hereditary cancer in clinical practice.

Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer

Gwen L. Alexander, K. Goddard, C. McCarty, 2013, Genetics in Medicine.

Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience

Kathleen F. Mittendorf, M. Kvale, L. Hindorff, 2022, HGG advances.

Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.

Jennifer L. Williams, A. Naleway, Sarah Ball, 2020, Vaccine.

ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial.

M. Dorschner, K. Goddard, B. Wilfond, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system

K. Goddard, B. Wilfond, J. Hunter, 2022, Hereditary cancer in clinical practice.

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories

K. Goddard, L. Le Marchand, H. Feigelson, 2012, BMC Research Notes.

Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system

Kathleen F. Mittendorf, Marian J. Gilmore, K. Goddard, 2022, Cancer.

The NextGen Study: patient motivation for participation in genome sequencing for carrier status

Marian J. Gilmore, K. Goddard, B. Wilfond, 2017, Molecular genetics & genomic medicine.

Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience

Yaping Yang, Katrina A B Goddard, Kathryn M Porter, 2018, Molecular genetics & genomic medicine.

Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews

Kathleen F. Mittendorf, K. Goddard, B. Wilfond, 2022, Hereditary cancer in clinical practice.

Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing

Marian J. Gilmore, K. Goddard, B. Wilfond, 2017, Journal of Genetic Counseling.

Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011))

Sara Chandros Hull, Robert C. Green, Sean D. Mooney, 2016 .

Predictors of Breastfeeding Initiation and Maintenance in an Integrated Healthcare Setting

S. Kurosky, A. Naleway, M. Thompson, 2017, Journal of human lactation : official journal of International Lactation Consultant Association.

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021

K. Vesco, Mark J. Lamias, M. Daley, 2021, MMWR. Morbidity and mortality weekly report.

Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting

K. Goddard, A. Rope, J. Schneider, 2019, Familial Cancer.

A case for expanding carrier testing to include actionable X‐linked disorders

D. Nickerson, K. Goddard, B. Wilfond, 2018, Clinical case reports.

Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.

D. Nickerson, M. Dorschner, K. Goddard, 2018, American journal of human genetics.

A decision aid for additional findings in genomic sequencing: Development and pilot testing.

K. Goddard, B. Wilfond, M. Leo, 2020, Patient education and counseling.

Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing

D. Nickerson, M. Dorschner, K. Goddard, 2016, Contemporary clinical trials.

Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing

K. Goddard, B. Wilfond, F. Lynch, 2018, Journal of Genetic Counseling.

“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening

K. Goddard, B. Wilfond, F. Lynch, 2015, Journal of Genetic Counseling.

Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Kathleen F. Mittendorf, Marian J. Gilmore, K. Goddard, 2021, JCO precision oncology.

Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations.

Kathleen F. Mittendorf, M. Dorschner, K. Goddard, 2021, Contemporary clinical trials.

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing

D. Nickerson, M. Dorschner, K. Goddard, 2017, Genetics in Medicine.

Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study

Kathleen F. Mittendorf, Marian J. Gilmore, K. Goddard, 2020, AJOB empirical bioethics.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2018, Genetics in Medicine.

Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample

Gwen L. Alexander, K. Goddard, C. McCarty, 2014, PloS one.

Oncologists' attitudes toward KRAS testing: a multisite study

Katrina A B Goddard, Gwen L. Alexander, Gwen L Alexander, 2013, Cancer medicine.

KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings

Gwen L. Alexander, K. Goddard, C. McCarty, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories

K. Goddard, L. Le Marchand, H. Feigelson, 2012, BMC Research Notes.

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Kathleen F. Mittendorf, Marian J. Gilmore, K. Goddard, 2021, Familial Cancer.

Kathleen F. Mittendorf, K. Goddard, A. Rope, 2019, Hereditary Cancer in Clinical Practice.

Integrating stakeholder feedback in translational genomics research: An ethnographic analysis of a study protocol’s evolution

K. Goddard, B. Wilfond, C. McMullen, 2020, Genetics in Medicine.

Patient actions and reactions after receiving negative results from expanded carrier screening

K. Goddard, B. Wilfond, J. Schneider, 2018, Clinical genetics.

Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.

S. Kurosky, D. Shay, A. Naleway, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening

K. Goddard, B. Wilfond, F. Lynch, 2018, PloS one.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2019, Genetics in Medicine.

Stakeholder perspectives on implementing a universal lynch syndrome screening program: A qualitative study of early barriers and facilitators

Katrina A B Goddard, Tia L Kauffman, K. Goddard, 2015, Genetics in Medicine.

Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol

H. Feigelson, A. Rope, S. Weinmann, 2021, Journal of personalized medicine.

Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing

K. Goddard, B. Wilfond, J. Berg, 2016, American journal of medical genetics. Part A.

Medical interpreter-mediated genetic counseling for Spanish preferring adults at risk for a hereditary cancer syndrome.

B. Wilfond, L. Karliner, M. Leo, 2023, Journal of genetic counseling.

An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial.

M. Dorschner, K. Goddard, B. Wilfond, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Kathleen F. Mittendorf, Charisma L. Jenkins, Marian J. Gilmore, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model.

Marian J. Gilmore, K. Goddard, B. Wilfond, 2020, Patient education and counseling.

Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making.

K. Goddard, B. Wilfond, C. Richards, 2018, Health affairs.

Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results

K. Goddard, B. Wilfond, J. Schneider, 2018, American journal of medical genetics. Part A.

A Weight-Loss Intervention Program Designed for Mexican–American Women: Cultural Adaptations and Results

V. Stevens, S. Vega-López, T. Kauffman, 2012, Journal of Immigrant and Minority Health.

Generating a taxonomy for genetic conditions relevant to reproductive planning

Diane M. Korngiebel, K. Goddard, B. Wilfond, 2016, American journal of medical genetics. Part A.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2019, Genetics in Medicine.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, K. Goddard, L. Hindorff, 2018, Genetics in Medicine.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Matthew S. Lebo, Victoria A. Miller, Jeffrey W. Pennington, 2016, American journal of human genetics.

Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project

Kathleen F. Mittendorf, K. Goddard, B. Wilfond, 2023, Journal of Community Genetics.

Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.

Marian J. Gilmore, D. Nickerson, M. Dorschner, 2018, American journal of human genetics.

PS2-11: Validation of KRAS Mutation Testing Across Five Certified Laboratories

K. Goddard, H. Feigelson, C. Richards, 2011, Clinical Medicine & Research.

Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study

Kathleen F. Mittendorf, Charisma L. Jenkins, Marian J. Gilmore, 2023, Public Health Genomics.